To assess possible areas of improvement, you will complete an assessment that asks to what extent you or your practice:
- Assesses all recommended biomarkers with multigene panel testing
- Incorporates multidisciplinary workflows and processes for tissue collection, biomarker testing, and biomarker test interpretation
- Implements protocols and procedures for biomarker testing using either in-house or outside labs
- Integrates biomarker testing protocols and results with your electronic health record
- Introduces workflows to reduce biomarker test turnaround times
- Establishes multidisciplinary frameworks to interpret biomarker test results prior to initiation of systemic therapy
- Implements guideline-directed therapy for patients with ERBB2-altered advanced/metastatic NSCLC Embeds treatment algorithms and protocols for advanced/metastatic NSCLC and actionable ERBB2 alterations within the electronic health record
You will receive a report card that summarizes your or your practice's performance relative to areas assessed. This serves as your baseline and guides development of your personalized action items.